Home LiteratureArticle Details
PMID: 567241 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Interaction of beta1H globulin with cell-bound C3b: quantitative analysis of binding and influence of alternative pathway components on binding.

The Journal of experimental medicine ·Vol. 147 ·No. 6 ·1978-06-01 ·Pages 1792-1805

Conrad DH, Carlo JR, Ruddy S

Abstract

Purified beta1H globulin (beta1H) was shown to bind to C3b coated cells by both immunofluorescent and radioactive tracer techniques. With EAC43, the amount of beta1H bound was directly proportional to the amount of C3 used to prepare the cells; EA, EAC14 and EAC14oxy2 bound very small amounts of beta1H. The C3b binding site on beta1H was labile in that not all of the purified 125I-beta1H was capable of binding to C3b, even when an excess of cell-bound C3b was present. Scatchard analysis of binding of beta1H to C3b-coated cells indicated an equilibrium constant of 10(9) L/M. Deviations from linearity were regularly found on Scatchard analyses. This was consistent with the hypothesis that the beta1H binding sites exhibit negative cooperativity in that as more sites become occupied, it becomes more difficult to fill the remaining sites. The stoichiometry of the reaction between C3b and beta1H was examined using EAC14oxy23 prepared with 131I-C3 and beta1H labeled with 125I. Between 0.5--0.8 beta1H molecules were bound per C3b molecule. Other alternative pathway components influenced the binding of 125I-beta1H to cell bound C3b. Both C3b and native C3 inhibited binding of labeled beta1H at an efficiency approximately 1/1,000 that of unlabeled beta1H. Factor B inhibited binding with 1/280 the efficiency of unlabeled beta1H. Properdin caused a dose-dependent increase in the binding of beta1H; this enhancement was abrogated if B was also present in the reaction mixture. Scatchard analysis indicated that the enhancement of beta1H binding by P resulted in an increased number of available binding sites rather than an increase in the affinity of binding.

MeSH Terms
Animals Binding Sites Complement C3/metabolism Complement C3b Inactivator Proteins/metabolism Complement Factor B/pharmacology Erythrocytes/metabolism Properdin/pharmacology Sheep
Chemicals
Complement C3 Complement C3b Inactivator Proteins Properdin Complement Factor B
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Conrad D H
Carlo J R
Ruddy S
References (26)
26 references, click to expand
  1. An improved technique of agar-gel electrophoresis on microscope slides.
    Clin Chim Acta. 1959 May;4(3):317-21 PMID: 13663230
  2. Modulation of the alternative complement pathways by beta 1 H globulin.
    J Exp Med. 1976 Nov 2;144(5):1147-63 PMID: 62817
  3. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    J Exp Med. 1977 Jul 1;146(1):257-70 PMID: 301546
  4. Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms.
    Proc Natl Acad Sci U S A. 1977 Apr;74(4):1683-7 PMID: 266208
  5. Activation of the alternative complement pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins.
    J Exp Med. 1977 Jul 1;146(1):22-33 PMID: 559720
  6. Purification of C3b inactivator and demonstration of its two polypeptide chain structure.
    J Immunol. 1977 Oct;119(4):1248-52 PMID: 894033
  7. Third component of human complement: purification from plasma and physicochemical characterization.
    Biochemistry. 1976 Oct 5;15(20):4513-21 PMID: 823964
  8. Control of the amplification convertase of complement by the plasma protein beta1H.
    Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72 PMID: 1067618
  9. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    J Immunol. 1971 Sep;107(3):742-50 PMID: 4999095
  10. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase.
    J Exp Med. 1975 Oct 1;142(4):856-63 PMID: 1185108
  11. The C3-activator system: an alternate pathway of complement activation.
    J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s PMID: 4105810
  12. A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.
    J Immunol. 1967 Dec;99(6):1162-72 PMID: 4168662
  13. Properties of highly purified human properdin.
    J Immunol. 1968 Jan;100(1):142-58 PMID: 4169693
  14. A method of trace iodination of proteins for immunologic studies.
    Int Arch Allergy Appl Immunol. 1966;29(2):185-9 PMID: 4160044
  15. Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement.
    J Exp Med. 1973 Dec 1;138(6):1305-13 PMID: 4202731
  16. The macrophage receptor for IgG: number and affinity of binding sites.
    J Immunol. 1973 Jun;110(6):1455-63 PMID: 4712920
  17. Enharncement of the hemolytic activity of the second component of human complement by oxidation.
    J Exp Med. 1967 Dec 1;126(6):1013-25 PMID: 4964564
  18. Binding parameters of the interaction between rat IgE and rat mast cell receptors.
    J Immunol. 1975 Jun;114(6):1688-91 PMID: 805173
  19. Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator.
    Science. 1976 Sep 10;193(4257):1011-3 PMID: 948757
  20. Comparison of the binding affinities of rabbit IgG fractions to the rabbit fetal yolk sac membrane: use of 22Na to facilitate quantitation of 125I-IgG binding.
    J Immunol. 1975 Oct;115(4):939-42 PMID: 1176769
  21. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  22. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    J Exp Med. 1969 May 1;129(5):1109-30 PMID: 5778786
  23. Genetic polymorphism of the third component of human complement (C'3).
    J Clin Invest. 1968 Sep;47(9):2181-91 PMID: 5675433
  24. Ultrastructural localization of the third and fourth components of complement on complement-cell complexes.
    Am J Pathol. 1968 Aug;53(2):253-61 PMID: 5667579
  25. The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
    J Immunol. 1968 Apr;100(4):691-8 PMID: 5645214
  26. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
    Immunochemistry. 1966 Mar;3(2):111-35 PMID: 5960883
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1978-06-01
Pages
1792-1805
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2184316
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com